Infraredx, Inc. is a privately-funded medical device company dedicated to helping provide practitioners with the information needed for enhanced clinical decision making in treating coronary artery disease. The company is committed to improving the safety and efficacy of coronary stenting and ultimately serving as part of a strategy to prevent initial coronary events. Through its TVC Imaging System, Infraredx is changing the way coronary artery disease is diagnosed and treated.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 08/22/13 | $25,000,000 | Strategic |
Nipro | undisclosed |
